Broadening Eligibility Criteria for Oncology Clinical Trials: Current Advances and Future Directions

被引：2
|
作者：
Rahman, Nam Atiqur [1 ]
Ison, Gwynn [1 ]
Beaver, Julia A. [1 ]
机构：
[1] US FDA, White Oak, MD 20903 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 108卷 / 03期
关键词：
D O I：
10.1002/cpt.1919
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：419 / 421
页数：3
相关论文
共 50 条
  • [1] Recommendations for Broadening Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials
    Siegel, Corey A.
    Rai, Victoria
    Outtier, An
    Vermeire, Severine
    Law, Cindy C. W.
    Sands, Bruce E.
    Abdulhamid, Asim
    Gearry, Richard
    McGuire, Josh
    Lindsay, James O.
    Panaccione, Remo
    Schweistein, Hagai
    Dotan, Iris
    Scarallo, Luca
    Griffiths, Anne
    Dubinsky, Marla C.
    JOURNAL OF CROHNS & COLITIS, 2024,
  • [2] Using real-word data to evaluate the effects of broadening eligibility criteria in oncology trials
    Sanz-Garcia, Enrique
    Haibe-Kains, Benjamin
    Siu, Lillian L.
    CANCER CELL, 2021, 39 (06) : 750 - 752
  • [3] ELIGIBILITY CRITERIA OF EARLY PHASE ONCOLOGY TRIALS
    Hohmann, N.
    Hilse, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S20 - S20
  • [4] Advances in Radiation Oncology: Current Status and Future Directions in India
    Rath, Goura Kishor
    Kumar Gandhi, Ajeet
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2022, 13 (SUPPL 1) : 58 - 60
  • [5] Advances in Radiation Oncology: Current Status and Future Directions in India
    Goura Kishor Rath
    Ajeet Kumar Gandhi
    Indian Journal of Surgical Oncology, 2022, 13 : 58 - 60
  • [6] Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement
    Kim, Edward S.
    Bruinooge, Suanna S.
    Roberts, Samantha
    Ison, Gwynn
    Lin, Nancy U.
    Gore, Lia
    Uldrick, Thomas S.
    Lichtman, Stuart M.
    Roach, Nancy
    Beaver, Julia A.
    Sridhara, Rajeshwari
    Hesketh, Paul J.
    Denicoff, Andrea M.
    Garrett-Mayer, Elizabeth
    Rubin, Eric
    Multani, Pratik
    Prowell, Tatiana M.
    Schenkel, Caroline
    Kozak, Marina
    Allen, Jeff
    Sigal, Ellen
    Schilsky, Richard L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (33) : 3737 - 3744
  • [7] Current and Future Directions of Clinical Trials for Ovarian Cancer
    Gardner, Ginger J.
    Jewell, Elizabeth L.
    CANCER CONTROL, 2011, 18 (01) : 44 - 51
  • [8] Neurosurgical Clinical Trials for Glioblastoma: Current and Future Directions
    Shah, Ashish H.
    Heiss, John D.
    BRAIN SCIENCES, 2022, 12 (06)
  • [9] Current Status and Future Directions for Clinical Trials Pharmacy
    La, Hyen-Oh
    Choi, Sun
    Lee, Soo-Kyung
    Ryu, Byeung-Eun
    Han, Ok-Yeon
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (06): : 969 - 975
  • [10] Evaluating the impact of performance status criteria on minority eligibility for oncology clinical trials.
    Bhandari, Sudip
    Mann, Jeremy
    Chawla, Jitesh
    Jain, Prerna
    Knight, Margot
    Lagor, Charles
    Mueller, Judith
    Raska, Paola
    Southwick, Steve
    Whyte, Warren
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18701 - E18701
12345